Novartis CEO Vas Narasimhan Talks Psoriasis Drug, China Growth, M&A
Bloomberg Talks
00:00
Strategic Investments and Market Resilience in Pharmaceuticals
This chapter explores how potential changes in U.S. administration policies could affect investment strategies and tariffs. It also examines the growth prospects of the psoriasis drug Cosentix, particularly in light of market conditions in China and its competitive edge.
Transcript
Play full episode
